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Abstract 
Background: As a primary source of Shiga‑toxin‑producing Escherichia coli (STEC) infection, cattle are often targeted 
to develop strategies for reducing STEC contamination. Monitoring the virulence potentials of STEC isolates from cat‑
tle is important for tracing contamination sources, managing outbreaks or sporadic cases, and reducing the risks for 
human infection. This study aimed to investigate the prevalence of STEC in cattle farm samples in South Korea and to 
assess their virulence potentials.
Results: In total, 63 STEC were isolated from 496 cattle farm samples, and temperature and rainfall affected STEC 
prevalence (p < 0.001). The O157 serogroup was most prevalent, followed by O108, O8, O84, O15, and O119. In the 
stx variant test, high prevalence of stx2a and stx2c (known to be associated with high STEC virulence) were observed, 
and stx2g, a bovine STEC variant, was detected in STEC O15 and O109. Additionally, stx1c was detected in eae‑positive 
STEC, suggesting genetic dynamics among the virulence genes in the STEC isolates. STEC non‑O157 strains were 
resistant to tetracycline (17.9%), ampicillin (14.3%), and cefotaxime (3.6%), while STEC O157 was susceptible to all 
tested antimicrobials, except cefotaxime. The antimicrobial resistance genes, blaTEM (17.5%), tetB (6.3%), and tetC 
(4.8%), were only detected in STEC non‑O157, whereas tetE (54.0%) was detected in STEC O157. AmpC was detected 
in all STEC isolates. Clustering was performed based on the virulence gene profiles, which grouped STEC O84, O108, 
O111, and O157 together as potentially pathogenic STEC strains. Finally, PFGE suggested the presence of a prototype 
STEC that continues to evolve by genetic mutation and causes within‑ and between‑farm transmission within the 
Gyeonggi province.
Conclusions: Considerable numbers of STEC non‑O157 were isolated from cattle farms, and the virulence and 
antimicrobial resistance features were different between the STEC O157 and non‑O157 strains. STEC from cattle with 
virulence or antimicrobial resistance genes might represent a threat to public health and therefore, continual surveil‑
lance of both STEC O157 and non‑O157 would be beneficial for controlling and preventing STEC‑related illness.
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Background
Since the identification of STEC O157:H7 as a foodborne 
zoonotic disease in 1982 [1], human infections by STEC 
have been reported worldwide [2, 3]. While numerous 
studies have focused on STEC O157:H7, the most well-
known and notorious serotype, >400 serotypes of STEC 
non-O157 have been implicated as etiological agents of 
several outbreaks and in sporadic cases of STEC infec-
tion [4]. Recently, STEC non-O157 infection cases have 
increased globally, highlighting the significance of inves-
tigating STEC non-O157 [3, 5, 6]. Among the STEC non-
O157 serotypes, O26, O45, O103, O111, O121, and O145, 
were reported as the six major STEC non-O157 linked to 
human diseases [7, 8]. Scallen et al. reported that ~63,000 
and 112,000 cases of foodborne illness caused by STEC 
O157 and non-O157, respectively, occur in the United 
States annually [2]. The progression of STEC infection 
varies, causing symptoms ranging from mild gastroin-
testinal symptoms to severe hemorrhagic colitis (HC) or 
hemolytic uremic syndrome (HUS) [9–11]. Predicting 
the risk of STEC is especially important for public health 
because STEC infection might develop into a life-threat-
ening disease, and is often associated with large and mul-
tinational outbreaks [10, 12, 13].
Although the pathogenicity of STEC is not fully 
understood, several virulence factors have been iden-
tified [10], including Shiga toxins, intimin, and the 
60-MDa plasmids (enterohemolysin or serine protease) 
[10]. Shiga toxins are the principal virulence factors of 
STEC, and two major types of Shiga toxins are known, 
Stx1 and 2 [14]. While the DNA sequence of stx1 is 
highly conserved and only a few stx1 variants have been 
reported (including stx1c and stx1d), the stx2 sequence 
shows 84–99% similarity among the stx2 variants [10, 
15]. Because the variants are related to the properties of 
Shiga toxin, subtyping of the stx variants is important 
for predicting the virulence potential of STEC in human 
infection [16]. Among Shiga toxin and its variants, Stx2 
is most associated with severe disease [17, 18]. Stx2 is a 
1000 times more toxic than Stx1 to renal microvascu-
lar endothelial cells, and Stx2 and Stx2c are more com-
monly reported in HUS patients [19–21]. Intimin, one 
of the proteins encoded by eae in the locus of entero-
cyte effacement, which is responsible for the forma-
tion of attaching and effacing (A/E) legions [10, 22, 23]. 
Several other factors also contribute to the virulence 
of STEC. EhxA (EHEC-enterohemolysin) disrupts the 
cytoplasmic membranes of mammalian cells [10, 24]. 
EspP (a serine protease) potentiates STEC colonization 
in the human gut [25, 26], and KatP (catalase peroxi-
dase) [27], SubAB (subtilase), and Saa (STEC autoag-
glutinating adhesin) are associated with the virulence of 
STEC [14, 28, 29].
Cattle are a primary source of STEC infection and are 
often targeted to develop strategies for reducing contam-
ination. Therefore, monitoring the virulence potentials 
of STEC isolates from cattle is important for tracing the 
sources of contamination, managing outbreaks or spo-
radic cases, and reducing the risks for human infection. 
This study investigated the prevalence of STEC O157 
and non-O157 in cattle farm samples in South Korea 
and assessed the virulence potentials of STEC isolates 
from these samples by characterizing stx variants, anti-
microbial resistance, and virulence genes. Finally, genetic 
analysis was performed to analyze the genetic dynamics 
of STEC strains isolated over a 4-year period.
Methods
Sample collection
Samples were collected from 15 cattle farms located in 
the Gyeonggi province in Korea during 2012–2015. Each 
farm was visited one to nine times during the sampling 
period (median  =  1, average  =  1.9), and cattle farm 
samples, including feces, ground soil, and water, were 
collected. Fecal samples were collected by direct rectal 
retrieval using disposable gloves. Environmental samples 
in the farm were collected using sterilized spatulas. Each 
sample collected had a mass of at least 5 g (or a volume 
of at least 5 mL for liquid samples). A total of 469 sam-
ples (419 fecal, 47 ground soil, one water, one raw milk, 
and one forage sample) were collected and transported 
immediately to the laboratory for STEC isolation.
Isolation of STEC strains
Shiga-toxin-producing Escherichia coli O157 was iso-
lated using a combination of standard culture methods 
and immunomagnetic separation methods, as described 
previously [30]. Briefly, 1  g or 1  mL of each sample 
was homogenized for 1  min with 9  mL of modified EC 
broth (Becton, Dickinson and Company, USA) supple-
mented with novobiocin (20 mg/L, Oxoid, USA) using a 
homogenizer, and then incubated overnight at 37 °C. The 
enriched culture suspension was then mixed with anti-E. 
coli O157 antibody-coated magnetic beads (Dynal, Inv-
itrogen, USA) and separated using a magnetic rack, as 
described in the manufacturer’s guidelines. The suspen-
sion was then tested for the formation of typical colonies 
in tellurite-added sorbitol MacConkey agar (T-SMAC; 
BD, USA), MacConkey agar (MAC; BD, USA), and 
CHROMagar O157 (CHROMagar Microbiology, France). 
To confirm STEC O157 isolation, the serotype of the 
colonies was tested using the E. coli O157 Latex Test Kit 
(Oxoid, UK).
To isolate STEC non-O157, multiplex polymerase 
chain reaction (PCR) combined with standard culture 
methods was used, as described previously [30]. Briefly, 
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one loop of enriched culture was streaked onto T-SMAC 
and tested for the presence of Shiga toxin genes by PCR 
as described below in the virulence gene profiling sec-
tion. The serotype of colonies harboring stx genes was 
then tested by conventional agglutination tests, using E. 
coli antisera (JoongKyeom, Ansan, Korea).
Antimicrobial‑susceptibility test
A standard disk-diffusion test was performed to deter-
mine antimicrobial susceptibility for the following 14 
antimicrobial drugs: ampicillin (AM, 10  µg), chloram-
phenicol (C, 30 µg), imipenem (IMP, 10 µg), tetracycline 
(TE, 30  µg), amikacin (AN, 30  µg), amoxicillin–clavu-
lanic acid (AMC, 20/10  µg), ceftazidime (CAZ, 30  µg), 
gentamicin (GM, 10 µg), nalidixic acid (NA, 30 µg), tri-
methoprim–sulfamethoxazole (STX, 1.25/23.75  µg), 
ceftriaxone (CRO, 30 µg), aztreonam (ATM, 30 µg), cefo-
taxime (CTX, 30 µg), and cefpodoxime (CPD, 10 µg). For 
quality control, E. coli ATCC 25922 was used as the refer-
ence strain. Antimicrobial susceptibility was interpreted 
as guided by the Clinical Laboratory Standard Institute 
(CLSI).
ESBL-producing STEC was detected following the 
CLSI ESBL phenotypic confirmatory test, which is a 
disk-diffusion test. Briefly, STEC isolates found to be 
resistant to cefpodoxime, ceftazidime, aztreonam, cefo-
taxime, or ceftriaxone were screened in the phenotypic 
confirmatory test. A standard double-disk test was per-
formed to confirm the ESBL phenotype, as described in 
the NCCL guidelines. Briefly, enriched STEC isolates 
were adjusted to 0.5 McFarland scale (McF), and 100 µL 
of the suspension was spread onto Mueller–Hinton agar. 
Antimicrobial disks containing ceftazidime  +  ceftazi-
dime–clavulanic acid or cefotaxime  +  cefotaxime–cla-
vulanic acid were placed on STEC-inoculated MH agar 
and incubated at 35 °C for 18 h. The ESBL phenotype was 
considered positive when the zone diameter resulting 
from the combination of the antimicrobial agent and cla-
vulanic acid was > 5 mm larger than that obtained using 
the antimicrobial test agent alone.
Detection of stx variants, virulence genes, 
and antimicrobial resistance genes
The presence of virulence and antimicrobial resistance 
genes was determined by PCR using a MyCycler thermal 
cycler (Bio-Rad Laboratories, USA). For DNA prepa-
ration, a single colony of each isolate was suspended 
in 1  mL of normal saline and centrifuged for 3  min at 
6000×g. The pellets were re-suspended with 200  µL of 
sterile water and boiled for 10 min. The suspension was 
centrifuged for 3  min at 6000×g, and the supernatant 
was used as the DNA template. PCR was conducted as 
described previously to detect Shiga toxin genes (stx1, 
stx1c, stx1d, stx2, stx2a, stx2c, stx2d, stx2e, stx2f, and 
stx2 g), virulence genes (eae, tir, espB, espD, ehxA, katP, 
espP, iha, subA, stcE, and saa), and antimicrobial resist-
ance genes (ampC, tetA, tetB, tetC, tetD, tetE, tetG, 
cat, cml, blaOXA, blaCMY, blaTEM, and qnr). The primer 
sequences and reaction conditions for each gene are 
summarized in Table 1.
Virulence gene profiling
A phylogenetic dendrogram of the virulence profiles was 
constructed by using the unweighted pair group method 
with arithmetic mean analysis (UPGMA) for binary data 
using BioNumerics, version 6.6 (Applied Maths NV, 
Belgium).
Pulsed‑field gel electrophoresis (PFGE)
Pulsed-field gel electrophoresis was performed follow-
ing the CDC PulseNet protocol using CHEF MAPPER 
(Bio-Rad, Hercules, CA, USA). Briefly, STEC colonies 
were suspended in cell suspension buffer (100 mM Tris: 
100  mM EDTA, pH 8.0) and then adjusted to the 4.0 
McFarland scale (McF). The adjusted cell suspension 
(400  µL) was mixed gently with 20  µL of proteinase K 
(20  mg/mL) and 400  µL of 1% SeaKem Gold melted 
agarose gel to build a plug. The plug was soaked in a 
proteinase K-containing cell lysis buffer (50  mM Tris: 
50 mM EDTA, pH 8.0 + 1% sarcosyl) for 2 h to lyse the 
cells, after which it was washed twice with sterile water 
for 15 min and then four times with TE buffer (10 mM 
Tris: 1 mM EDTA, pH 8.0) for 15 min. The plug was then 
digested with 50 U of XbaI restriction enzyme for 2  h. 
PFGE was performed with a pulse time of 2.16–54.17  s 
for STEC O157 and 6.76–35.38  s for STEC non-O157; 
S. Braenderup ATCC BAA664 was used as a size ladder 
marker. A Dice similarity coefficient with a UPGMA den-
drogram was generated based on 1.5% tolerance windows 
and 1.5% optimization, using BioNumerics, version 6.6 
(Applied Maths NV, Belgium).
Statistical analysis
To identify factors potentially associated with preva-
lence, farm-management factors, environmental fac-
tors, and animal information were collected, if present 
(Table  2). Farm-management factors (farm size, ground 
soil hygiene, and diet), and animal information (age and 
breed) were obtained from the veterinarian in charge of 
each farm. Environmental factors included average tem-
perature on sampling date, humidity, and rainfall within 
3 days prior to sampling, which were obtained from the 
data provided by the Meteorological Administration 
(http://www.kma.go.kr/weather/observation/past_table.
jsp). The association between STEC prevalence and farm 
management and environmental factors was analyzed by 
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Table 1 Primer sequences and the PCR conditions used in this study
Target  
gene
Nucleotide sequences (5′–3′) PCR conditions Amplicon  
size (bp)
References
Denaturation Annealing Extension Cycle
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using the Chi squared test, and the association between 
STEC prevalence and animal factors was analyzed by 
Fisher’s exact test. The statistical analysis was performed 
using SPSS, version 22.0 (SPSS IBM, New York, NY, 
USA), and the variables were considered to be signifi-
cantly associated when the p value was <0.05.
Results
STEC prevalence in cattle farms
Of 496 samples collected from 29 visits to 15 farms, 
63 STEC were isolated from 17 visits to seven farms 
(Table 2). Most STEC were isolated from feces (54 from 
adult cow and three from calves), and six STEC were iso-
lated from ground soil. No STEC were isolated from feed, 
water, or milk samples. The farm prevalence of STEC var-
ied from 0.0 to 90.0%, but no farm management factors 
were found to be associated with STEC prevalence. STEC 
prevalence was significantly higher when the average 
temperature was above 20  °C (p < 0.001, two tailed Chi 
squared test, odds ratio [OR] = 2.3), and when rain was 
reported within 3 days prior to sampling (p < 0.001, two 
tailed Chi squared test, OR =  3.5). Moreover, while the 
STEC prevalence was higher in calves (3/19; 15.8%) than 
in adults (54/405; 13.3%), the difference was not signifi-
cant. By breed, STEC prevalence was significantly higher 
in beef cattle (4/9; 44.4%) than in dairy cattle (50/396; 
12.63%; p < 0.05, two-tailed Fisher’s exact test, OR = 5.5).
Serogroup
Of the 63 STEC isolates, 61 were serogrouped. Thirty-five 
(55.6%) and 26 (41.3%) isolates were found to be STEC 
O157 and non-O157, respectively, whereas two isolates 
were non-typeable (NT). Among STEC non-O157, the 
most common serogroup was O108 (five isolates, 7.5%), 
followed by O8 and O84 (four isolates each, 6.0%), O15 
and O119 (three isolates each, 4.5%), O109 and O111 
(two isolates each, 3.0%), and O55, O169, and O185 (one 
isolate each, 1.5%).
Prevalence of Shiga toxin and its variant genes
The Shiga toxin gene types of the 63 STEC isolates were 
determined by PCR. STEC harboring both stx1 and stx2 
(28/63, 41.8%) were the most common strains, followed 
by STEC with either stx1 (13/63, 19.4%) or stx2 (22/63, 
32.8%; Table 3). STEC harboring stx1 were only detected 
in STEC non-O157 (O55, O84, O108, and O111), while 
STEC O157 harbored stx2 only or both stx1 and stx2 with 
a similar distribution. Of the 35 STEC harboring stx1, 34 
(97.1%) carried the stx1c variant, while no stx1d variants 
were detected. All STEC harboring stx2 (n  =  50) car-
ried at least one stx2 variant, stx2a (45; 90.0%), stx2c (34; 
68.0%), and stx2 g (5; 10.0%). Stx2d, stx2e, and stx2f were 
not detected. When the distribution of the stx variants 
was analyzed based on serotypes, stx2a was observed in 
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94.3%), and O185 (1/1, 100.0%); and stx2 g in O15 (3/3, 
100.0%) and O109 (2/2, 100.0%).
Antimicrobial resistance of the STEC isolates
Disc diffusion tests were conducted using 14 antimicro-
bial agents. While resistance was observed for TE (five 
isolates, 17.9%), AMP (four isolates, 14.3%), and CTX 
(one isolate, 3.6%) in 28 STEC non-O157 strains, resist-
ance was not observed in 35 STEC O157 strains. Four 
and five STEC O157 and non-O157, respectively, showed 
intermediate resistance to CTX. The STEC isolates 
showing complete or intermediate resistance to CTX 
were further tested for ESBL-producing STEC, but none 
of them had the ESBL phenotype (Table 4).
All of the 63 STEC isolates carried more than one anti-
microbial resistance genes. Of 13 tested antimicrobial 
resistance genes, genes tetA, tetD, tetG, cat, cml, blaOXA, 
blaCMY, and qnr were not detected. All STEC isolates car-
ried ampC gene (63/63; 100.0%), and 11 isolates carried 
blaTEM, (11/63; 17.5%) gene. Of tetracycline resistance 
gene, tetE (34/63; 54.0%) was the most prevalent, fol-
lowed by tetB (4/63; 6.3%) and tetC (3/63; 4.8%) (Table 4).
Table 3 Shiga toxin genotypes of STEC isolates
NT non-typeable for STEC serogroup
Shiga toxin gene type Serotype No. of isolates stx variants
stx1c stx2a stx2c stx2g
stx1 only O55 1 1 – – –
O84 4 4 – – –
O108 5 5 – – –
O111 2 2 – – –
NT 1 1 – – –
Subtotal 13 13 – – –
stx2 only O15 3 – 0 0 3
O109 2 – 0 0 2
O119 3 – 3 0 0
O157 18 – 18 18 0
O169 1 – 1 0 0
O185 1 – 1 1 0
Subtotal 28 – 23 19 5
Both stx1 and stx2 O8 4 3 4 0 0
O157 17 17 17 15 0
NT 1 1 1 0 0
Subtotal 22 21 22 15 0
Total 63 34 45 34 5
Table 4 Phenotypic and genotypic antimicrobial resistance profiles of STEC isolates
a  All STEC showed susceptibility on chloramphenicol, imipenem, amikacin, amoxicillin–clavulanic acid, ceftazidime, gentamicin, nalidixic acid, trimethoprim–
sulfamethoxazole, ceftriaxone, aztreonam, and cefpodoxime on standard disk-diffusion test
b  Antimicrobial resistance profiles were tested for 35 and 28 STEC O157 and non-O157 strains, respectively
c  Antimicrobial resistance genes of tetA, tetD, tetG, cat, cml, blaOXA, blaCMY, and qnr were not detected from all STEC isolates
d  Four STEC O157 and five non-O157 showed intermediate resistance to cefotaxime
Antimicrobial class Phenotypic profiles Genotypic profiles
Antimicrobiala No. of STEC  isolatesb (%) Antimicrobial resistance  genec No. of STEC isolates (%)
STEC O157 STEC non‑O157b STEC O157 STEC non‑O157
Β‑lactams Ampicillin 0 (0.0) 4 (14.3) ampC 35 (100.0) 28 (100.0)
Cefotaximed 0 (0.0) 1 (3.6) BlaTEM 0 (0.0) 11 (36.3)
Tetracycline Tetracycline 0 (0.0) 5 (17.9) tetB 0 (0.0) 4 (14.3)
tetC 0 (0.0) 3 (10.7)
tetE 34 (97.1) 0 (0.0)
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Virulence gene profiles
The prevalence of virulence genes was investigated. The 
prevalence of each virulence gene was as follows: eae 
(77.8%), tir (76.2%), espB (74.6%), espD (65.1%), ehxA 
(92.1%), katP (55.6%), espP (84.1%), iha (66.7%), subA 
(7.9%), stcE (65.1%), and saa (9.5%).
When clustering analysis was conducted based on the 
profiles of the virulence genes, including Shiga toxin and 
its variant genes, six clusters were generated (based on 
50% similarity; Fig. 1). STEC strains in clusters 1, 2, and 
6 were composed of a single serotype each, O119, O185, 
and O55, respectively. The strains showed 100% preva-
lence of eae, ehxA, stx2, and stx2c in cluster 1; espP, stx2, 
stx2a, and stx2c in Cluster 2; and tir, stx1, and stx1c in 
cluster 3. Strains in cluster 3 were characterized as having 
stx2 g variants, and belonged to the O15 and O109 sero-
groups. Cluster 4 was composed of STEC O84, O108, 
O111, and O157 strains with a high prevalence of eae, 
tir, espB, espD, ehxA, katP, espP, iha, stcE, stx2, stx2a, and 
stx2c. Strains in cluster 5 were characterized as having 
subA and saa (Table 5). 
Fig. 1 UPGMA dendrogram of STEC O157 and non‑O157 based on the profiles of virulence genes. Six clusters were generated with the UPGMA 
method based on 50% similarity. a0806‑3, 0806‑5, 0806‑20, 0823‑4, 0823‑5, 0823‑8, 0909‑5, 0909‑9, 0909‑11, 0909‑14, 0909‑15, 0909‑16, 0909‑17 
(O157). b0827‑1, 0827‑2, 0827‑3, 0827‑5, 0827‑6, 0827‑7, 0827‑8, 0827‑9, 0827‑10, 0814‑4, 0814‑5, 0814‑7, 0814‑8, 0814‑11, 0814‑20, 0814‑31, 1013‑19 
(O157)
Table 5 Prevalence of virulence genes in each cluster
NT non-typeable
Cluster No. of  
isolates
Serotype (no. of isolates  
in each serotype)
Prevalence of virulence genes (%)
eae tir espB espD ehxA katP espP iha subA stcE Saa
1 3 O119 (3) 100.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0
2 1 O185 (1) 0.0 0.0 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0
3 5 O15 (3), O109 (2) 0.0 20.0 0.0 0.0 40.0 0.0 40.0 40.0 0.0 0.0 0.0
4 47 O84 (4), O108 (5), O111 (2), O157 (35), NT (1) 97.9 93.6 100.0 87.2 100.0 74.5 93.6 78.7 0.0 87.2 0.0
5 6 O8 (4), O169 (1), NT (1) 0.0 33.3 0.0 0.0 100.0 0.0 100.0 50.0 83.3 0.0 100.0
6 1 O55 (1) 0.0 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
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Genetic relatedness of the STEC isolates
The PFGE patterns of XbaI-digested STEC O157 
and non-O157 were analyzed to determine how the 
clonal relatedness of STEC isolates changed with 
temporo-spatial variation. The DNA fingerprints of 35 
STEC O157 strains showed high similarity, generating 16 
different PFGE profiles with 15–20 discernible fragments 
(mean: 17.4, median: 17). The 16 PFGE profiles clustered 
Fig. 2 Phylogenetic analysis of STEC isolates from cattle. The UPGMA method was used with a 1.5% optimization and 1.5% tolerance window using 
Bionumerics software. aCP Cheongpyeong, GP Gapyeong, YP Yangpyeong. bAll STEC O157 strains were belonged to cluster 4. cAMP ampicillin, CTX 
cefotaxime, TE tetracycline. a STEC O157 strains were clustered into four groups (based on 90% similarity). b STEC non‑O157 strains clustered into 
12 groups (based on 80% similarity), STEC strains with the same serotype clustered together, except for STEC O8. The STEC O169 strains were not 
typeable by PFGE
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into four groups, based on 90% similarity; each group 
was composed of one to 23 isolates (Fig. 2a).
Pulsed-field gel electrophoresis was performed for 
STEC strains belonging to 10 different serogroups, other 
than O157 and two strains that were non-typeable for 
the O serotype. Diverse PFGE patterns of XbaI-digested 
STEC non-O157 were observed, resulting in 20 different 
PFGE profiles with 14–23 discernible fragments (mean: 
18.2, median: 19), except for one isolate (0911-15), which 
was untypeable by PFGE. A UPGMA dendrogram, gen-
erated using Dice coefficient analysis, clustered STEC 
non-O157 into 12 different groups, based on 80% simi-
larity. Each group was composed of one to five strains, 
and STEC strains belonging to the same serotype were 
grouped together regardless of differences in the sam-
pling period or geographical location of each farm 
(Fig. 2b).
Discussion
The prevalence of STEC in 15 different cattle farms, viru-
lence-gene profiles, antimicrobial resistance, and genetic 
relatedness of STEC isolates were analyzed to investigate 
the virulence potentials of STEC in cattle farm.
During the sampling period, 63 STEC were isolated 
from 469 cattle farm samples collected from 15 cat-
tle farm in Gyeonggi province in South Korea. Numer-
ous studies are ongoing to identify the factors associated 
with STEC prevalence. In this study, high temperature 
and rain were found to be associated with STEC preva-
lence. Similarly, a previous study reported higher STEC 
prevalence in hot seasons than in cold seasons [31–33]. 
In addition, rainfall has been considered an important 
transmission factor for STEC. The pathogens may be 
transported via sediments to vast geographical regions as 
far away as 32 km, resulting in an increased prevalence in 
the environment [34, 35]. Many published reports have 
shown that STEC O157 prevalence is higher in calves, 
especially in post-weaned calves, than in adult cat-
tle [36–38]. However, no obvious link between age and 
STEC non-O157 prevalence has been reported, and some 
investigators even observed a higher prevalence of STEC 
non-O157 in adult groups [37, 39, 40]. In this study, the 
adult group showed a higher prevalence for STEC O157 
(calves: 0/19, 0.0% vs. adults: 31/405, 7.7%) and a lower 
prevalence for STEC non-O157 (calves: 3/19, 15.8% vs. 
adult: 24/405, 5.9%). This discrepancy with respect to 
previous data may be due to the collection of a relatively 
small number of calf feces samples, compared to the 
number of samples collected from adults. Thus, further 
studies may be needed to investigate the effect of age on 
STEC non-O157 prevalence. Here, beef cattle showed 
higher STEC prevalence than dairy cattle. Although only 
a few beef cattle were included in this study, the results 
are consistent with data from previous studies [31, 33].
While many studies have focused on the O157 serotype, 
the significance of STEC non-O157 in human infection 
has become clear recently [3, 7]. In this study, 11 different 
serotypes of STEC were identified and >40% of the STEC 
were non-O157, highlighting the need for active surveil-
lance of STEC non-O157 and understanding their viru-
lence potential in humans. Of the identified serotypes, 
O8, O15, O55, O84, O109, O111, O119, and O157 have 
been reported frequently in dairy cattle worldwide [39]. 
Among them, several serogroups have also been reported 
frequently in human clinical cases. The O111 serogroup 
is the second most common serogroup in human infec-
tions, and is the most common cause of HUS. Moreover, 
it accounts for half the STEC non-O157 outbreaks. The 
O15, O84, and O119 serogroups also frequently cause 
human illness [7, 39]. In addition, human-pathogenic 
STEC O8, O15, and O109 serotypes have been detected 
in food samples, highlighting the possible transmission of 
STEC via the food chain [41].
The genetic variation of Shiga toxin causes changes in 
its amino acid composition, which may directly influ-
ence the virulence of STEC, resulting in a change in the 
toxin receptor tropism or toxicity of Shiga toxin [11]. In 
this study, high prevalence of stx1c, stx2a, and stx2c was 
detected. The stx1c variants are associated with ovine-
originated STEC strains [42–44], but the high prevalence 
of stx1c in buffaloes, cattle, and goats was reported to 
account for 80% of the stx1 variants, indicating a wide 
distribution of stx1c variants in STEC of bovine origin 
[45]. stx1c variants have been found as stx1c only or in 
combination with stx1, stx2, or stx2d. However, in this 
study, combinations involving stx1, stx1c, stx2, stx2a, and 
stx2c (16 isolates); stx1, stx1c, stx2, and stx2a (six iso-
lates); and stx1 and stx1c (13 isolates) were newly found. 
In addition, stx1c-producing STEC is considered a sub-
set of eae-negative STEC, and is responsible for asymp-
tomatic or mild disease [42, 44, 46]. However, in this 
study, 29 stx1c-producing STEC harbored eae. The stx1c 
variants in eae-positive STEC strains might be resulted 
from the dynamics of virulence genes. Of the stx2 vari-
ants, stx2a, stx2c, and stx2d variants have been impli-
cated in high STEC virulence [21, 47]. While stx2d was 
not detected in the current study, the high prevalence of 
stx2a, and stx2c suggested the wide distribution of poten-
tially pathogenic STEC strains in cattle farms. The stx2g 
variant was detected from five STEC non-O157 (three 
O15 and two O109 STEC). Previously, the stx2g variant 
has been identified from various sources, including cattle, 
beef or beef-containing products, and humans, suggest-
ing a possible route of exposure of these STEC types via 
the food chain [41, 48].
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To evaluate the virulence potentials of STEC strains 
isolated from cattle farms, the phenotypic and genotypic 
antimicrobial resistance features and the prevalence of 
virulence genes were investigated. In this study, all STEC 
isolates were susceptible to all tested antimicrobials, 
except for AMP, TE, and CTX. Resistance to AMP and 
TE in diverse sources, including cattle or beef products, 
have commonly been reported in previous studies [28, 
29, 49], but resistance to CTX is uncommon, with only 
one isolate (of 722) from a bovine source being reported 
to date [50]. CTX, a third generation cephalosporin, 
is used as an indicator to identify ESBL production. 
Although ESBL production was not identified in this 
study, the presence of CTX-resistant STEC indicates the 
need for implementing antimicrobial resistance control 
strategies to prevent the generation and spread of ESBL-
producing STEC.
In addition, all the STEC strains that exhibited resist-
ance to AMP, TE, and CTX were STEC non-O157 
strains. Genotypic antimicrobial features also varied by 
its serotype. While antimicrobial resistance genes of tetB, 
tetC, and blaTEM were only observed in STEC non-O157 
strains, tetE was detected only in STEC O157 (34/35; 
97.1%). These results suggest that antimicrobial resist-
ance is higher in STEC non-O157 than in STEC O157, 
consistent with previous studies [49, 50]. While the anti-
microbial resistance gene ampC was amplified from all 
tested STEC isolates, only four STEC non-O157 strains 
exhibited phenotypic resistance. Since many genes and 
mechanisms, including efflux pumps or intrinsic resist-
ance, are involved in the development of resistance 
features, genetic determinants may not represent the 
phenotypic resistance features [51, 52].
The prevalence of virulence genes in each serotype was 
either 0 or 100%, except for tir, espP, and iha, indicat-
ing the sero-specific feature of virulence genes. To esti-
mate the virulence potentials of STEC strains that might 
cause a risk to public health, clustering analysis was per-
formed based on the virulence gene profiles. Six clusters 
were generated, and sero-specific features were observed 
in each cluster. Cluster 1 was composed of O119 STEC, 
which has 100% prevalence of the well-known virulence 
factors eae and ehxA. The association between intimin 
(encoded by eae) and STEC virulence has been reported 
previously, and serogroup O119 has been detected in 
human infections [4, 7]. This indicates that the STEC 
isolates in Cluster 1 might have the potential to cause 
human illness. Most of the other STEC strains were 
grouped in Cluster 4 (47/63, 74.6%), and these strains 
harbored most of the virulence genes at a high frequency, 
except for subA and saa. The katP and stcE gene prod-
ucts are believed to promote STEC virulence by assisting 
STEC colonization in the intestines and degrading the 
protective layers in the intestines, respectively [27, 53]. A 
high prevalence of these two genes was reported for sero-
pathogroups A and B, which are responsible for severe 
STEC illness [54]. In this study, all of the O157 and O111 
serotypes, which belonged to sero-pathotypes A and B, 
also belonged to Cluster 4, indicating the high virulence 
potential of the STEC in Cluster 4. Cluster 5 was charac-
terized by the presence of subA and saa, and consisted of 
O8, O169, and NT STEC. subA is purported to increase 
STEC virulence. Saa also increases STEC virulence by 
assisting in adherence to host cells in eae-negative STEC 
[55, 56]. On the other hand, the STEC in Clusters 2, 3, 
and 6 appeared to be less pathogenic to humans. High 
prevalence of espP, iha, and ehxA was reported regard-
less of sero-pathotype, suggesting the absence of a strong 
association between these genes and STEC virulence 
[54].
Pulsed-field gel electrophoresis analysis was performed 
to understand the clonal relatedness of STEC strains iso-
lated from cattle farms located in different regions of the 
Gyeonggi province in Korea during 2012–2015. For the 
STEC O157 strains, those isolated from the same farm 
during the same sampling period had indistinguish-
able PFGE profiles except for a few isolates from farms 
4, 7, 11, and 15, which showed one to three different 
bands. Considering that a single nucleotide mutation at 
a restriction enzyme site causes three fragment differ-
ences [57], a minor genetic variation may have occurred 
within the farm. In addition, STEC O157 from farm 4 
showed high similarity between the 2012 and 2013 iso-
lates. Phylogenetic analysis combined most isolates into 
group 3, which consisted of isolates from five farms in 
three different geographical locations. These results indi-
cated the possible presence of a prototype of STEC O157 
in the Gyeonggi province with a minor genetic varia-
tion, which led to within- and between-farm transmis-
sion during 2012–2013. However, STEC O157 isolates 
from farm 15 showed a higher degree of polymorphism; 
these isolates clustered in groups 1 and 2 (STEC strains 
isolated in 2014) and group 3 (STEC strains isolated in 
2012). These results indicated that the prototype of STEC 
O157 in farm 15 might have changed in 2014. Because 
all the farms were located in the Gyeonggi province and 
the longest distance between farms was approximately 
60  km, temporal effects may have been less important. 
While a high degree of genetic diversity was observed in 
STEC non-O157, they were grouped together for strains 
with the same serotype. STEC O8, O15, O84, and O111 
were isolated multiple times and shared genotypic simi-
larity over the 3-year period within the serogroup, imply-
ing that these STEC strains have endured and continue to 
survive, causing within-farm transmission.
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Conclusions
Shiga-toxin-producing Escherichia coli prevalence dif-
fered greatly between farms, and temperature and rain-
fall affected the farm prevalence. A considerable number 
of STEC non-O157 stains were isolated, and different 
virulence and antimicrobial resistance features were 
observed between STEC O157 and non-O157 strains. 
While a high prevalence of virulence genes was observed 
in STEC O157 strains, the antimicrobial resistance rate 
was higher in STEC non-O157 strains. In addition, the 
stx1c variant was detected in eae-positive STEC, sug-
gesting genetic dynamics among virulence genes in 
STEC isolates. Finally, PFGE analysis revealed the pres-
ence of a prototype STEC, which continues to evolve by 
genetic mutation and causes within- and between-farm 
transmission within the Gyeonggi province. Our results 
suggested that STEC from cattle have a high virulence 
potential and represent a threat to public health. There-
fore, continual surveillance of both STEC O157 and non-
O157 would be beneficial for controlling and preventing 
STEC illness.
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